News
Piper Sandler Maintains Overweight on Aptose Biosciences, Maintains $5 Price Target
3 Apr 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Maintains Buy on Aptose Biosciences, Maintains $23 Price Target
27 Mar 24
News, Price Target, Analyst Ratings
Aptose Biosciences Q4 EPS $(1.44) Beats $(1.59) Estimate
26 Mar 24
Earnings, News
Recap: Aptose Biosciences Q4 Earnings
26 Mar 24
Earnings
Earnings Scheduled For March 26, 2024
26 Mar 24
Earnings
Aptose Biosciences's Earnings: A Preview
25 Mar 24
Earnings
Piper Sandler Maintains Overweight on Aptose Biosciences, Lowers Price Target to $5-Report Released on 31 January 2024
1 Feb 24
News, Price Target, Analyst Ratings
Press releases
Aptose Reports Results for the Fourth Quarter and Full Year 2023
26 Mar 24
Earnings, Press Releases
Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday, March 26, 2024
18 Mar 24
News, Press Releases
Aptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement with Hanmi Pharmaceutical, Including Full Exercise of Over-Allotment Option
31 Jan 24
Press Releases